Citations

Showing 10 of 108152 citations.

Postoperative Management After Total Pharyngolaryngectomy Using the Free Ileocolon Flap
Manrique, Oscar J. , Sabbagh, M. Diya , Kapoor, Trishul , Ciudad, Pedro , Chen, Hung‐Chi

Mayo Clinic

Annals of Plastic Surgery | July 1, 2019 | Volume: 84 | Issue: 1 | Pages: 68-72

10.1097/sap.0000000000001953 | PMID 31246671 Get It

IntroductionManagement after total pharyngolaryngectomy with free ileocolon flaps can be challenging. Adequate postoperative surgical guidelines are essential to avoid complications. Factors, such as agitation, hypotension, or prolonged mechanical ventilation, might compromise final outcomes. Herein, we describe our experience in the early postoperative care of patients after total pharyngolaryngectomy with immediate reconstruction using the free ileocolon flap.MethodsThis is a retrospective review of all patients who underwent total pharyngolaryngectomy and immediate reconstruction using the free Ileocolon flap. Demographics, etiology of resection, neoadjuvant therapy, surgical time, method of sedation, postoperative use of vasopressors, length of intensive care unit (ICU) stay, time of discontinuation of mechanical ventilation, and complications were recorded and analyzed.ResultsBetween 2010 and 2015, a total of 34 patients underwent total pharyngolaryngectomy and immediate reconstruction using the free Ileocolon flap. The most common cause of total pharyngolaryngectomy was cancer. Twenty-eight patients had neoadjuvant therapy (radiation). The average surgical time was 11.5 hours (range, 8–14.5 hours), average length of ICU stay was 3 days (range, 2–15 days) with an average time for mechanical ventilation cessation of 3 days (range, 1–20 days). Midazolam and dexmedetomidine were the most common sedatives used during surgery and in the ICU period. Three patients required vasopressors due to hypotension, 2 had unplanned self-extubation from the tracheostomy site, 2 experienced postoperative bleeding, 1 had pneumonia, 4 required unplanned return to the operating room, 2 had partial flap loss, and 1 had complete flap loss.ConclusionsOverall, a majority of patients recovered well postoperatively with minimal complications and low rate of reoperation. Our research provides a foundation to develop a risk-stratified approach to determine the need for an ICU admission or early transfer to floor care.
Magnetization Transfer Imaging Is Unaffected by Decreases in Renal Perfusion in Swine
Jiang, Kai , Ferguson, Christopher M. , Woollard, John R. , Landes, Vanessa , Krier, James D., Zhu, Xiangyang , Nayak, Krishna S. , Lerman, Lilach O.

Mayo Clinic

Investigative Radiology | July 1, 2019 | Volume: 54 | Issue: 11 | Pages: 681-688

10.1097/rli.0000000000000588 | PMID 31261296 Get It

Objectives Multiparametric renal magnetic resonance imaging (MRI), including diffusion-weighted imaging, magnetic resonance elastography, and magnetization transfer imaging (MTI), is valuable in the noninvasive assessment of renal fibrosis. However, hemodynamic changes in diseased kidneys may impede their ability to measure renal fibrosis. Because MTI assesses directly tissue content of macromolecules, we test the hypothesis that MTI would be insensitive to renal hemodynamic changes in swine kidneys with acute graded ischemia. Materials and Methods Seven domestic pigs underwent placement of an inflatable silicone cuff around the right renal artery to induce graded renal ischemia. Multiparametric MRI was performed at baseline, 50%, 75%, and 100% renal artery stenosis as well as reperfusion. Measurements included regional perfusion, R2*, apparent diffusion coefficient (ADC), stiffness, and magnetization transfer ratio (MTR) using arterial spin-labeled MRI, blood oxygenation–dependent MRI, diffusion-weighted imaging, magnetic resonance elastography, and MTI, respectively. Histology was performed to rule out renal fibrosis. Results During graded ischemia, decreases in renal perfusion were accompanied with elevated R2*, decreased ADC, and stiffness, whereas no statistically significant changes were observed in the MTR. No fibrosis was detected by histology. After release of the obstruction, renal perfusion showed only partial recovery, associated with return of kidney R2*, ADC, and stiffness to baseline levels, whereas cortical MTR decreased slightly. Conclusions Renal MTI is insensitive to decreases in renal perfusion and may offer reliable assessment of renal structural changes.
Low-Pressure Lumbar Provocation Discography According to Spine Intervention Society/International Association for the Study of Pain Standards Does Not Cause Acceleration of Disc Degeneration in Patients With Symptomatic Low Back Pain
McCormick, Zachary L. , Plastaras, Christopher T. , Walega, David R., Huddleston, P.M. , Moussallem, Charbel D. , Geske, Jennifer R. , Verdoorn, Jared T. , Maus, Timothy P. , Lehman, Vance T. , Huddleston, Paul, Moussallem, Charbel, Carr, Carrie M. , Kennedy, David J. , Geske, Jennifer , Huddleston, Paul M

Mayo Clinic

Spine | July 1, 2019 | Volume: 44 | Issue: 19 | Pages: E1161-E1168

10.1097/brs.0000000000003085 | PMID 31261283 Get It

Study Design. Retrospective matched cohort study. Objective. To determine if low-pressure lumbar provocation discography (PD) results in long-term accelerated disc degeneration, internal disc disruption, or disc herniation in patients with symptomatic low back pain (LBP). Summary of Background Data. Study of subjects without clinically-significant LBP suggests that high-pressure PD may accelerate disc degeneration. Methods. Consecutive patients with symptomatic LBP who underwent magnetic resonance imaging (MRI), PD, and repeat MRI more than 7 years later, but did not undergo subsequent spinal fusion surgery, were included. Punctured discs were matched (1:2 to 1:4) to corresponding discs in a control cohort by age, BMI, Pfirrmann score (±2), and presence of disc herniation; control cohort inclusion required MRIs for symptomatic LBP, separated by more than 7 years. The primary outcome of the study was a progression in Pfirrmann score category (I–II, III–IV, V). MRI disc-to-CSF T2 signal-intensity ratio, disc height, disc herniations, high intensity zones (HIZs), and Modic changes were assessed. Results. Baseline and follow-up MRIs were available for 77 discs exposed to PD, and for 260 discs in the matched control cohort. There was no difference in the proportion of punctured discs that advanced in Pfirrmann score category in the PD group (17%, 95% CI 9–27%) compared with corresponding discs in the Control group (21%, 95% CI 17–27%), P = 0.3578, or in non-punctured discs in the PD group (35%, 95% CI 21–51%) compared with corresponding discs in the Control group (34%, 95% CI 27–42%), P = 0.1169. There were no differences in disc-to-CSF T2 signal-intensity ratio, presence of disc herniations, HIZs, or Modic changes following puncture in the PD versus matched cohort discs or in the non-punctured PD cohort discs versus corresponding control cohort discs (P > 0.05). Conclusion. Patients with symptomatic LBP who underwent low-pressure PD, but who did not undergo a subsequent spinal fusion surgery, developed disc degeneration and new disc herniations at a similar rate to corresponding discs in matched control patients. Level of Evidence: 3
The future of scientific publishing
Sarr, Michael G.

Mayo Clinic

British Journal of Surgery | July 1, 2019 | Volume: 106 | Issue: 8 | Pages: 963-964

10.1002/bjs.11285 | PMID 31260583 Get It

Open access for all?
Hypoplastic Left Heart Syndrome: An Overview for Primary Care Providers
Javed, Rabia, Cetta, Frank , Said, Sameh M. , Olson, Timothy M. , Qureshi, M. Yasir , Qureshi, Muhammad Y , Olson, Timothy M , O’Leary, Patrick

Mayo Clinic

Pediatrics In Review | July 1, 2019 | Volume: 40 | Issue: 7 | Pages: 344-353

10.1542/pir.2018-0005 | PMID 31263042 Get It

Hypoplastic left heart syndrome is one of the most complex congenital heart diseases and requires several cardiac surgeries for survival. The diagnosis is usually established prenatally or shortly after birth. Each stage of surgery poses a unique hemodynamic situation that requires deeper understanding to manage common pediatric problems such as dehydration and respiratory infections. Careful multidisciplinary involvement in the care of these complex patients is improving their outcome; however, morbidity and mortality are still substantial. In this review, we focus on the hemodynamic aspects of various surgical stages that a primary care provider should know to manage these challenging patients.
The Use of Cryoanalgesia in Minimally Invasive Repair of Pectus Excavatum: Lessons Learned
Parrado, Raphael H. , Lee, Justin , McMahon, Lisa , Clay, Conner, Powell, Jordan , Kang, Paul , Notrica, David M. , Ostlie, Daniel J. , Bae, Jae-O , Parrado, Raphael, McMahon, Lisa E

Mayo Clinic

Journal of Laparoendoscopic & Advanced Surgical Techniques | July 1, 2019 | Volume: 29 | Issue: 10 | Pages: 1244-1251

10.1089/lap.2019.0203 | PMID 31259649 Get It

Abstract Introduction: Cryoanalgesia has been applied to minimally invasive repair of pectus excavatum (MIRPE). After implementation of cryoanalgesia at our institution, we had several cases of delayed postoperative pneumothorax. The purpose of this study was to critically evaluate the complications and efficacy of cryoanalgesia in MIRPE. Materials and Methods: We performed a single institution retrospective review of pediatric patients undergoing MIRPE from June 2017 to July 2018. Multimodal (MM) analgesia was used in all patients. In addition, most patients received either cryoanalgesia or elastomeric pain pumps (EPPs) as adjuncts to postoperative analgesia. Primary outcome was clinically significant late pneumothorax. Secondary outcomes included length of stay, pain scores, opiate use, and bar displacement requiring reoperation. Results: A total of 101 patients undergoing MIRPE were included: 45 had cryoanalgesia + MM, 45 EPP + MM, and 11 MM alone. Postoperative tube thoracostomy was placed in 5 patients with cryoanalgesia (4 pneumothorax; 1 effusion), 1 patient with EPP (1 pneumothorax), and none in MM alone ( P = .25). Pain scores at discharge were similar in all groups. Cryoanalgesia patients received less overall inpatient opioids than other groups ( P < .05). No patient required reoperation for bar displacement. Conclusion: Cryoanalgesia is an effective therapy for pain control in MIRPE. Because thermal injury can occur on the lung and chest wall with cryoanalgesia, we implemented techniques to limit and prevent this injury. Cryoanalgesia offers a safe alternative for postoperative analgesia with significant reduction in inpatient opioid requirement. Larger prospective studies are required to assess the long-term impact and complications of cryoanalgesia.
Dipeptidyl Peptidase 4 Inhibition Increases Postprandial Norepinephrine via Substance P (NK1 Receptor) During RAAS Inhibition
Wilson, Jessica R. , Kerman, Scott Reza Jafarian , Hubers, Scott , Nian, Hui , Grouzmann, Eric , Eugster, Philippe J. , Mayfield, Dustin, Brown, Nancy J. , Kerman, Scott Jafarian , Hubers, Scott A , Grouzmann, Eric , Eugster, Philippe J , Brown, Nancy J , Yu, Chang

Mayo Clinic

Journal of the Endocrine Society | July 1, 2019 | Volume: 3 | Issue: 10 | Pages: 1784-1798

10.1210/js.2019-00185 | PMID 31528826 Get It

Abstract Context Dipeptidyl peptidase 4 (DPP4) inhibitors may increase the risk of heart failure. Decreased degradation of vasoactive peptides like substance P [also degraded by angiotensin-converting enzyme (ACE)] and Y1 agonists peptide YY (PYY 1-36) and neuropeptide Y (NPY 1-36) could contribute. Objective This study tested the hypothesis that there is an interactive effect of DPP4 inhibition and ACE inhibition (vs antihypertensive control subjects) on vasoactive peptides after a mixed meal. Participants and Design Fifty-three patients with type 2 diabetes and hypertension were randomized to double-blind treatment with ramipril, valsartan, or amlodipine for 15 weeks in parallel groups. During the 5th, 10th, and 15th weeks, participants also received placebo + placebo, sitagliptin 100 mg/d + placebo, and sitagliptin + aprepitant 80 mg/d in random order. On the last day of each crossover treatment, participants underwent a mixed-meal study. Results Sitagliptin increased postprandial glucagon-like peptide-1 and decreased glucose in all antihypertensive groups. Sitagliptin increased NPY 1-36 and decreased Y2 agonists NPY 3-36 and PYY 3-36 in all groups. During ramipril or valsartan, but not amlodipine, sitagliptin increased postprandial norepinephrine; substance P receptor blockade with aprepitant prevented this effect. Despite increased norepinephrine, sitagliptin decreased postprandial blood pressure during ACE inhibition. Conclusion DPP4 inhibition increases postprandial concentrations of the Y1 agonist NPY 1-36. During treatment with an ACE inhibitor or angiotensin receptor blocker, DPP4 inhibition increased postprandial norepinephrine through a substance P receptor–dependent mechanism. Increased NPY 1-36 and norepinephrine could increase risk of heart failure but did not result in higher postprandial blood pressure.
Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEART
Upadhya, Bharathi , Rocco, Michael V. , Morgan, Tim, Blackshear, Joseph L., Hundley, William Greg, Oparil, Suzanne , Soliman, Elsayed Z. , Cohen, Debbie L. , Hamilton, Craig A. , Cho, Monique E. , Kostis, William J. , Raj, Dominic S. , Townsend, Ray, Vasu, Sujethra, Zamanian, Sara, Kitzman, Dalane W. , Hundley, W. Gregory , Blackshear, Joseph, Rocco, Michael V , Pajewski, Nicholas M. , Papademetriou, Vasilios , Rodríguez, Carlos J. , Zamanian, Sara

Mayo Clinic

Hypertension | July 1, 2019 | Volume: 74 | Issue: 2 | Pages: 276-284

10.1161/hypertensionaha.119.13073 | PMID 31256724 Get It

In observational studies, left ventricular mass (LVM) and structure are strong predictors of mortality and cardiovascular events. However, the effect of hypertension treatment on LVM reduction and its relation to subsequent outcomes is unclear, particularly at lower blood pressure (BP) targets. In an ancillary study of SPRINT (Systolic Blood Pressure Intervention Trial), where participants were randomly assigned to intensive BP control (target systolic BP target <120 mm Hg) versus standard BP control (<140 mm Hg), cardiac magnetic resonance imaging was performed at baseline and 18-month follow-up to measure: LVM, volumes, ejection fraction, and native T1 mapping for myocardial fibrosis. At baseline, 337 participants were examined (age: 64±9 years, 45% women); 300 completed the 18-month exam (153 intensive control and 147 standard control). In the intensive versus standard BP control group at 18 months, there was no difference in change in LVM (mean±SE =−2.7±0.5 g versus −2.3±0.7 g; P =0.368), ejection fraction, or native T1 ( P =0.79), but there was a larger decrease in LVM/end-diastolic volume ratio (−0.04±0.01 versus −0.01±0.01; P =0.002) a measure of concentric LV remodeling. There were fewer cardiovascular events in the intensive control group, but no significant association between the reduced events and change in LVM or any other cardiac magnetic resonance imaging measure. In SPRINT-HEART, contrary to our hypothesis, there were no significant between-group differences in LVM, function, or myocardial T1 at 18-month follow-up. These results suggests that mediators other than these LV measures contribute to the improved cardiovascular outcomes with intensive BP control.
Silent and non‐silent thromboembolic events after ventricular tachycardia ablation: Modifiable risk with postprocedure anticoagulation?
Siontis, Konstantinos C. , Killu, Ammar M.

Mayo Clinic

Journal of Cardiovascular Electrophysiology | July 1, 2019 | Volume: 30 | Issue: 8 | Pages: 1197-1199

10.1111/jce.14051 | PMID 31257655 Get It

AbstractThere is increasing recognition of silent and clinically apparent thromboembolic events after left‐sided ventricular tachycardia (VT) ablation. However, unlike atrial fibrillation ablation procedures where postablation oral anticoagulation (OAC) is universal, there is significant practice variation in OAC use after VT ablation. Herein, we review the data on post‐VT ablation thromboembolism and evidence on the use of OAC, we suggest that OAC merits consideration in most cases after a balanced assessment of risks and benefits in individual patients, and we discuss future directions.
Monoclonal gammopathy‐associated thrombotic microangiopathy
Yui, Jennifer , Garceau, Daniel, Jhaveri, Kenar D. , Wanchoo, Rimda, Bijol, Vanesa, Hassoun, Hani , Russell, Stephen J. , Leung, Nelson , Dispenzieri, Angela , Leung, Nelson , Russell, Stephen J , Jhaveri, Kenar D , Glezerman, Ilya G , Dispenzieri, Angela

Mayo Clinic

American Journal of Hematology | July 1, 2019 | Volume: 94 | Issue: 10 | Pages: No page available

10.1002/ajh.25569 | PMID 31257598 Get It